Comerica (NYSE:CMA) reported quarterly earnings of $2.58 per share which beat the analyst consensus estimate of $2.55 by 1.18 percent. This is a 55.42 percent increase over earnings of $1.66 per share from the same period last year.
Nektar Therapeutics Q4 EPS $(0.32) Beats $(0.45) Estimate, Sales $22.02M Miss $22.09M Estimate
Nektar Therapeutics (NASDAQ:NKTR) reported quarterly losses of $(0.32) per share which beat the analyst consensus estimate of $(0.45) by 28.89 percent. This is a 59.49 percent increase over losses of $(0.79) per share